SCM
IMI

Southport Capital Management’s Intermolecular, Inc. IMI Stock Holding History

Southport Capital Management’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3
Closed – – 570
2018
Q3 		$0 Buy
+3
New +$4 ﹤0.01% 626

Other funds holding IMI

RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Southport Capital Management's IMI Position: Q4 2018 in Review

Southport Capital Management sold out of Intermolecular, Inc. (IMI) in Q4 2018, closing a stake of 3 shares.

Southport Capital Management first reported a position in IMI in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 32 funds tracked by Wall St. Rank hold IMI as of Q4 2018.

  • Southport Capital Management reported no remaining Intermolecular, Inc. position as of Q4 2018 after selling out during the quarter.
  • Southport Capital Management sold 3 Intermolecular, Inc. shares in Q4 2018.
  • Southport Capital Management first reported a position in Intermolecular, Inc. in Q3 2018 and held it in 1 quarter.
  • Southport Capital Management's Intermolecular, Inc. position peaked at $0 in Q3 2018.
  • 32 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q4 2018.

Based on Southport Capital Management's 13F filing for Q4 2018, filed 18 Jan 2019.